Omnea

Omnea — Funding & Company Data

Financial overview and investor data for Omnea.

High confidence data Last verified 4 months ago

Founded

2022

Stage

Series b

Total Raised

$75M

HQ

London, United Kingdom

Team

51-200

Model

sales-led

Analyst Take

Founded in 2022, Omnea has demonstrated a remarkably aggressive and successful fundraising trajectory, securing three major rounds in just over three years. This rapid progression from a $5M Seed round to a $50M Series B underscores significant market traction and investor conviction in its AI-native approach to procurement orchestration. The velocity of funding suggests the company is successfully capturing a critical need in the enterprise market for streamlined supplier management and cost control.

The quality of Omnea's investor syndicate is exceptionally high, which serves as a major de-risking factor. The rounds involve a who's who of top-tier venture capital, from early-stage leaders like First Round Capital and Point Nine to growth-stage powerhouses Accel, Insight Partners, and Khosla Ventures. This backing not only provides capital but also lends immense credibility and access to a network of talent and potential customers, positioning Omnea as a likely category leader.

With $50 million from its Series B, the company has a substantial runway, likely sufficient for 24-36 months of operations and aggressive expansion. The stated use of funds includes tripling headcount and opening US offices, indicating a clear strategy for scaling its go-to-market teams and product development. From a competitive standpoint, this war chest allows Omnea to compete effectively against other well-funded players in the procurement software space.

For a potential user, this financial profile is highly encouraging. The company is not a startup struggling for survival; it is a well-capitalized, high-growth company backed by investors with a track record of building durable, market-leading enterprise software businesses. This translates into a lower risk of vendor failure and a higher likelihood of continued product innovation and support.

Stability

With a $50 million Series B secured in late 2025 from premier investors, Omnea's financial stability is high. The company is well-capitalized to operate and grow for at least the next 2-3 years without needing additional financing.

Growth

The company is on a high-growth trajectory, evidenced by three significant funding rounds in three years and stated plans to triple its headcount and expand its US presence. Revenue was reported to have grown eightfold in the year leading up to its Series A, indicating rapid customer adoption.

For Buyers

For a potential buyer, Omnea's strong and recent funding from top-tier VCs significantly mitigates vendor risk. This financial stability makes it a safe choice for a long-term commitment to a critical procurement workflow tool.

Funding Timeline

Series B $50M September 2025

Investors: Insight Partners, Khosla Ventures, Accel, Point Nine, First Round Capital, Prosus

Series A $20M October 2024

Investors: Accel, First Round Capital, Point Nine

Seed $5M June 2022

Investors: First Round Capital, Point Nine, Entrepreneur First

Notable Investors

Insight Partners Khosla Ventures Accel First Round Capital Point Nine Prosus

Sources

Get AI tools & workflows in your inbox

Practical picks, honest comparisons, and how teams actually use them — no spam.